These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 3257544

  • 1. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW.
    Nature; 1988 Jan 07; 331(6151):82-4. PubMed ID: 3257544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HIV infection is blocked in vitro by recombinant soluble CD4.
    Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT.
    Nature; 1988 Jan 07; 331(6151):76-8. PubMed ID: 2829022
    [Abstract] [Full Text] [Related]

  • 5. Receptor molecule blocks HIV.
    Weiss RA.
    Nature; 1988 Jan 07; 331(6151):15. PubMed ID: 2829021
    [No Abstract] [Full Text] [Related]

  • 6. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK, Sieh M, Pious DA, Reinherz EL.
    Nature; 1989 Jun 15; 339(6225):548-51. PubMed ID: 2543930
    [Abstract] [Full Text] [Related]

  • 7. Structural features of CD4 required for binding to HIV.
    Ibegbu CC, Kennedy MS, Maddon PJ, Deen KC, Hicks D, Sweet RW, McDougal JS.
    J Immunol; 1989 Apr 01; 142(7):2250-6. PubMed ID: 2538505
    [Abstract] [Full Text] [Related]

  • 8. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS, Nicholson JK, Cross GD, Cort SP, Kennedy MS, Mawle AC.
    J Immunol; 1986 Nov 01; 137(9):2937-44. PubMed ID: 2428879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP.
    J Immunol; 1989 May 01; 142(9):3091-7. PubMed ID: 2468713
    [Abstract] [Full Text] [Related]

  • 11. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
    Landau NR, Warton M, Littman DR.
    Nature; 1988 Jul 14; 334(6178):159-62. PubMed ID: 3260352
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J, Cervenák L, Tóth FD, Prohászka Z, Horváth L, Kerekes K, Beck Z, Bácsi A, Erdei A, Peerschke EI, Füst G, Ghebrehiwet B.
    Clin Immunol; 2001 May 14; 99(2):222-31. PubMed ID: 11318594
    [Abstract] [Full Text] [Related]

  • 14. HIV infection of primate lymphocytes and conservation of the CD4 receptor.
    McClure MO, Sattentau QJ, Beverley PC, Hearn JP, Fitzgerald AK, Zuckerman AJ, Weiss RA.
    Nature; 2001 May 14; 330(6147):487-9. PubMed ID: 2446142
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of CD4 in HIV binding and entry.
    Sattentau QJ, Moore JP.
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct 29; 342(1299):59-66. PubMed ID: 7904348
    [Abstract] [Full Text] [Related]

  • 20. T cells can present antigens such as HIV gp120 targeted to their own surface molecules.
    Lanzavecchia A, Roosnek E, Gregory T, Berman P, Abrignani S.
    Nature; 1988 Aug 11; 334(6182):530-2. PubMed ID: 2841610
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.